U.S.-based pharmaceutical firm Eli Lilly and Company on Tuesday announced it will spend $30 million over five years to fight the rising burden of non-communicable diseases (NCDs) in developing nations, the Indianapolis Star reports (Swiatek, 9/13). According to a Lilly press release, the company is launching the Lilly NCD Partnership “to identify new models of patient care that increase treatment access and improve outcomes for underserved people” (9/13).
Access to Health Services
“The United States and British governments have launched a four-year, Shs213.5 billion [US$75 million] project to increase the use of contraceptive services among Ugandans,” Uganda’s Daily Monitor reports. “Through the project, the United States Agency for International Development (USAID) and the UK’s Department for International Development (DfID) will provide family planning services in all parts of Uganda,” with Britain contributing 35 million Pound Sterling (US$55 million) and the U.S. contributing US$20 million, the newspaper reports.
“The number of cases and deaths from breast and cervical cancer is rising in most countries across the world, especially in poorer nations where more women are dying at younger ages, according to a global study of the diseases” by researchers from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, Reuters reports. Between 1980 and 2010, breast cancer cases more than doubled worldwide, rising from 641,000 cases in 1980 to 1.6 million cases in 2010, while deaths from breast cancer rose from 250,000 a year to 425,000 a year, according to the study, which was published in the Lancet on Thursday, Reuters notes. The “number of cervical cancer cases rose from 378,000 cases in 1980 to 454,000 in 2010, and deaths from cervical cancer rose at almost the same pace as cases,” the news service writes (Kelland, 9/15). The majority of new cases occurred among women under age 50 in low-income nations, BBC News writes (Briggs, 9/14).
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) “are spreading at an alarming rate in Europe and will kill thousands unless health authorities halt the pandemic, the World Health Organization (WHO) said on Wednesday” during the launch of “a new regional plan to find, diagnose and treat cases of the airborne infectious disease more effectively,” Reuters reports. “The WHO said that if the plan is fully implemented — at an estimated cost of $5 billion — 127,000 people will be successfully treated for drug-resistant TB and 120,000 deaths will be averted by 2015,” according to the news agency (Kelland, 9/13).
“Innovation can transform a company, a culture, and even the world. But innovation doesn’t have to come in the form of a gadget. It can come in the form of a smiling neighbor knocking at a family’s door, toting some basic supplies and the skills to address matters of life and death,” Melinda Gates, co-chair of the Bill & Melinda Gates Foundation writes in a Huffington Post opinion piece.
“[F]ar too many children in Kenya and other African countries continue to suffer unnecessarily each year due to the misdiagnosis of fever, which contributes to the deaths of nearly three million children of less than five years of age from malaria and pneumonia,” Willis Akhwale, head of Kenya’s Department of Disease Prevention and Control in the Ministry of Public Health and Sanitation, writes in a Daily Nation opinion piece, saying that health care workers “desperately need a test that can quickly and accurately identify and distinguish between fever-causing diseases.”
PRI’s “The World” highlights the state of mental health care in Uganda in an examination of how the exclusion of mental health from the Millennium Development Goals (MDGs) has, according to some advocates, held back mental health as a global health issue. Julius Kayiira, director of Mental Health Uganda, an organization that provides social support, job training and care to people with mental illness, “says organizations like his face an enormous funding gap, and he blames that gap, in part, on the United Nations,” according to “The World.”
U.N. Secretary-General Ban Ki-moon on Tuesday is expected “to announce a significant expansion of the organization’s ambitious global program to tackle infant and maternal mortality and boost access to reproductive health over coming years,” the Financial Times reports. The announcement “will highlight the doubling of commitments from governments, the private sector and non-profit organizations on funding and policy initiatives for the ‘Every Woman Every Child’ program,” the newspaper writes (Raval et al., 9/19). The announcement comes “[a]s the U.N. General Assembly opens a new session” and is “being called on [by the international community] to provide more family planning services to hundreds of millions of women,” according to VOA News (DeCapua, 9/19).
The health care system in the refugee camps in Dadaab, Kenya, which were established “long ago,” are “currently challenged and stretched by the recent influx of refugees,” UNFPA Executive Director Babatunde Osotimihen writes in this BMJ Group Blogs entry, noting that efforts are underway “to strengthen the existing system with supplies [and] human resources at clinic and outreach levels” to increase access. UNFPA is working “to improve reproductive health care in Dadaab and in accessible parts of Somalia through the provision of related life-saving medical supplies and equipment, which will lead to a reduction in adult and child morbidity and death,” he writes.
Twenty aid agencies on Wednesday issued an open letter (.pdf) “urg[ing] the international community to change its approach to Somalia ‘and enhance diplomatic engagement with the parties to the conflict, to ensure the unhindered delivery of humanitarian aid,’” particularly before the rainy season brings the threat of disease, IRIN reports (9/21).